Abstract:Introduction: Glycogen storage disease type III (GSDIII) is a rare genetic disease caused by mutations in the AGL gene encoding the glycogen debranching enzyme (GDE). The deficiency of this enzyme, involved in cytosolic glycogen degradation, leads to pathological glycogen accumulation in liver, skeletal muscles and heart. Although the disease manifests with hypoglycemia and liver metabolism impairment, the progressive myopathy is the major disease burden in adult GSDIII patients, without any curative treatment currently available. Methods: Here, we combined the self-renewal and differentiation capabilities of human induced pluripotent stem cells (hiPSCs) with cutting edge CRISPR/Cas9 gene editing technology to establish a stable AGL knockout cell line and to explore glycogen metabolism in GSDIII. Results: Following skeletal muscle cells differentiation of the edited and control hiPSC lines, our study reports that the insertion of a frameshift mutation in AGL gene results in the loss of GDE expression and persistent glycogen accumulation under glucose starvation conditions. Phenotypically, we demonstrated that the edited skeletal muscle cells faithfully recapitulate the phenotype of differentiated skeletal muscle cells of hiPSCs derived from a GSDIII patient. We also demonstrated that treatment with recombinant AAV vectors expressing the human GDE cleared the accumulated glycogen. Discussion: This study describes the first skeletal muscle cell model of GSDIII derived from hiPSCs and establishes a platform to study the mechanisms that contribute to muscle impairments in GSDIII and to assess the therapeutic potential of pharmacological inducers of glycogen degradation or gene therapy approaches.

Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing.

Generation of an ASGR1 Homozygous Mutant Human Embryonic Stem Cell Line WAe001-A-6 Using CRISPR/Cas9.

Construction of a GLI3 Compound Heterozygous Knockout Human Embryonic Stem Cell Line WAe001-A-20 by CRISPR/Cas9 Editing.

Generation of a Lamin A/C Knockout Human Induced Pluripotent Stem Cell Line (Zjulli007-A) Via CRISPR/Cas9

Generation of a DKK1 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-21 Using CRISPR/Cas9.

Generation of a DMD loss-of-function mutant human embryonic stem cell lines by CRISPR base editing

Generation of a KCNJ11 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-12 Using CRISPR/Cas9.

Generation of a SMO Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-16 by CRISPR/Cas9 Editing.

Generation of NERCe003-A-3, a P53 Compound Heterozygous Mutation Human Embryonic Stem Cell Line, by CRISPR/Cas9 Editing.

Generation of a Homozygous HDAC6 Knockout Human Embryonic Stem Cell Line by CRISPR/Cas9 Editing.

Generation of an ASS1 Heterozygous Knockout Human Embryonic Stem Cell Line, WAe001-A-13, Using CRISPR/Cas9.

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells

Generation of a Well-Characterized Homozygous Chromodomain-Helicase-DNA-Binding Protein 4G1003D Mutant hESC Line Using CRISPR/eCas9 (ULIEGEe001-A-1)

[Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

[Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

Generation of an Abcc8 Heterozygous Mutation Human Embryonic Stem Cell Line Using CRISPR/Cas9

Generation of a Bag1 Homozygous Knockout Mouse Embryonic Stem Cell Line Using CRISPR/Cas9.

Generation of a TLR2 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-64 Using CRISPR/Cas9 Editing

Generation of ID1/3 knockout human embryonic stem cell lines (WAe009-A-2A and WAe009-A-2B) derived from H9 using CRISPR/Cas9

Establishment of a CPAMD8-GFP Reporter Human Embryonic Stem Cell Line, IBBDe001-B, Using CRISPR/Cas9 Editing

Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing.

Generation of an ASGR1 Homozygous Mutant Human Embryonic Stem Cell Line WAe001-A-6 Using CRISPR/Cas9.

Construction of a GLI3 Compound Heterozygous Knockout Human Embryonic Stem Cell Line WAe001-A-20 by CRISPR/Cas9 Editing.

Generation of a Lamin A/C Knockout Human Induced Pluripotent Stem Cell Line (Zjulli007-A) Via CRISPR/Cas9

Generation of a DKK1 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-21 Using CRISPR/Cas9.

Generation of a DMD loss-of-function mutant human embryonic stem cell lines by CRISPR base editing

Generation of a KCNJ11 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-12 Using CRISPR/Cas9.

Generation of a SMO Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-16 by CRISPR/Cas9 Editing.

Generation of NERCe003-A-3, a P53 Compound Heterozygous Mutation Human Embryonic Stem Cell Line, by CRISPR/Cas9 Editing.

Generation of a Homozygous HDAC6 Knockout Human Embryonic Stem Cell Line by CRISPR/Cas9 Editing.

Generation of an ASS1 Heterozygous Knockout Human Embryonic Stem Cell Line, WAe001-A-13, Using CRISPR/Cas9.

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells

Generation of a Well-Characterized Homozygous Chromodomain-Helicase-DNA-Binding Protein 4G1003D Mutant hESC Line Using CRISPR/eCas9 (ULIEGEe001-A-1)

[Establishment of a stable HEK293T cell line with c.392G&gt;T (p.131G&gt;V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

[Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].

Generation of an Abcc8 Heterozygous Mutation Human Embryonic Stem Cell Line Using CRISPR/Cas9

Generation of a Bag1 Homozygous Knockout Mouse Embryonic Stem Cell Line Using CRISPR/Cas9.

Generation of a TLR2 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-64 Using CRISPR/Cas9 Editing

Generation of ID1/3 knockout human embryonic stem cell lines (WAe009-A-2A and WAe009-A-2B) derived from H9 using CRISPR/Cas9

Establishment of a CPAMD8-GFP Reporter Human Embryonic Stem Cell Line, IBBDe001-B, Using CRISPR/Cas9 Editing

[Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in G6PD gene using CRISPR/Cas9 technique].